Inactivation of STAT3 inhibits bleomycin-induced fibrosis as a model of early, inflammation-driven fibrosis, but also demonstrate potent anti-fibrotic effects in TBRact-induced fibrosis as a model of late, non-inflammatory stages of SSc with endogenous activation of fibroblasts52. Here, STAT3 is linked to systemic sclerosis.